Cargando…

Patterns of Migraine in Postmenopausal Women: A Systematic Review

INTRODUCTION: Migraine prevalence is higher in fertile than in postmenopausal women. However, few literature data are available on the prevalence and characteristics of migraine after the menopause and on the effect of hormones in postmenopausal women with migraine. METHODS: We performed a systemati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ornello, Raffaele, Caponnetto, Valeria, Frattale, Ilaria, Sacco, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989683/ https://www.ncbi.nlm.nih.gov/pubmed/33776441 http://dx.doi.org/10.2147/NDT.S285863

Ejemplares similares

Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021)

Different effects of air microembolism through patent foramen ovale in patients with migraine: A quantitative electroencephalogram case series
por: Ornello, Raffaele, et al.
Publicado: (2022)

The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
por: Ornello, Raffaele, et al.
Publicado: (2019)

Migraine in menopausal women: a systematic review
por: Ripa, Patrizia, et al.
Publicado: (2015)

Acute and Preventive Management of Migraine during Menstruation and Menopause
por: Ornello, Raffaele, et al.
Publicado: (2021)

Applying a biopsychosocial model to migraine: rationale and clinical implications
por: Rosignoli, Chiara, et al.
Publicado: (2022)

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
por: Ornello, Raffaele, et al.
Publicado: (2020)

Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials
por: Ornello, Raffaele, et al.
Publicado: (2021)

Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities
por: Pistoia, Francesca, et al.
Publicado: (2022)

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
por: Ornello, Raffaele, et al.
Publicado: (2020)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
por: Ornello, Raffaele, et al.
Publicado: (2022)

Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index
por: Sette, Lucia, et al.
Publicado: (2022)

Peripheral vascular dysfunction in migraine: a review
por: Sacco, Simona, et al.
Publicado: (2013)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023)

Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications
por: Rosignoli, Chiara, et al.
Publicado: (2022)

Social Distancing in Chronic Migraine during the COVID-19 Outbreak: Results from a Multicenter Observational Study
por: Di Stefano, Vincenzo, et al.
Publicado: (2021)

Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Migraine and body mass index categories: a systematic review and meta-analysis of observational studies
por: Ornello, Raffaele, et al.
Publicado: (2015)

Migraine and hemorrhagic stroke: data from general practice
por: Ornello, Raffaele, et al.
Publicado: (2015)

Association between response to triptans and response to erenumab: real-life data
por: Frattale, Ilaria, et al.
Publicado: (2021)

Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort
por: Gentile, Eleonora, et al.
Publicado: (2021)

Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
por: Delussi, Marianna, et al.
Publicado: (2020)

EHMTI-0392. Migraine and risk of ischemic heart disease: a systematic review and meta-analysis of observational studies
por: Sacco, S, et al.
Publicado: (2014)

O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
por: Ornello, Raffaele, et al.
Publicado: (2015)

Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns
por: Frattale, Ilaria, et al.
Publicado: (2021)

Editorial: Spotlight on resistant and refractory migraine
por: Ornello, Raffaele, et al.
Publicado: (2023)

How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
por: Tiseo, Cindy, et al.
Publicado: (2019)

Visual Disturbances Spectrum in Pediatric Migraine
por: Frattale, Ilaria, et al.
Publicado: (2023)

Migraine in women: the role of hormones and their impact on vascular diseases
por: Sacco, Simona, et al.
Publicado: (2012)

Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications
por: Dresler, Thomas, et al.
Publicado: (2019)

O032. Associations between any headache and obesity: results from a systematic review and meta-analysis of observational studies
por: Degan, Diana, et al.
Publicado: (2015)

Migraine and sleep disorders: a systematic review
por: Tiseo, Cindy, et al.
Publicado: (2020)

A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
por: Ornello, Raffaele, et al.
Publicado: (2020)

Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol
por: Diamanti, Susanna, et al.
Publicado: (2021)

InterMiG: international differences in the therapeutic approach to migraine patients in specialized headache centers
por: Gago-Veiga, AB, et al.
Publicado: (2021)

Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
por: Ornello, Raffaele, et al.
Publicado: (2021)

Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
por: Lambru, Giorgio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6m1v69cvl4acqt4af20pbl3l50